Medical Care
Global Precision Cancer Therapeutics Market Research Report 2025
- May 05, 25
- ID: 226974
- Pages: 102
- Figures: 102
- Views: 37
The global market for Precision Cancer Therapeutics was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Precision Cancer Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Precision Cancer Therapeutics.
The Precision Cancer Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Precision Cancer Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Precision Cancer Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AbbVie
Astellas Pharma U.S., Inc
AstraZeneca PLC
Bayer AG
Bristol-Myers Squibb Company
Clovis Oncology, Inc.
Dendreon Pharmaceuticals LLC
Eli Lilly & Company
EMD Serono, Inc. (Merck KgaA)
Eisai Co., Ltd.
Exelixis, Inc.
Gilead Sciences, Inc.
GlaxoSmithKline
Johnson & Johnson
Merck & Co., Inc.
Novartis AG
Otsuka Holdings Co., Ltd.
Pfizer, Inc.
Puma Biotechnology, Inc.
Roche (F. Hoffman-La Roche, Ltd.)
Sanofi/Genzyme
Seagen Inc.
Takeda
Segment by Type
Monoclonal Antibodies
Kinase Inhibitors
Angiogenesis Inhibitors
Proteasome Inhibitors
CAR-T Therapies
Other Precision Therapies
Segment by Application
Breast Cancer
Lung Cancer
Prostate Cancer
Colon and Rectal Cancer
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Precision Cancer Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Precision Cancer Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Precision Cancer Therapeutics.
The Precision Cancer Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Precision Cancer Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Precision Cancer Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AbbVie
Astellas Pharma U.S., Inc
AstraZeneca PLC
Bayer AG
Bristol-Myers Squibb Company
Clovis Oncology, Inc.
Dendreon Pharmaceuticals LLC
Eli Lilly & Company
EMD Serono, Inc. (Merck KgaA)
Eisai Co., Ltd.
Exelixis, Inc.
Gilead Sciences, Inc.
GlaxoSmithKline
Johnson & Johnson
Merck & Co., Inc.
Novartis AG
Otsuka Holdings Co., Ltd.
Pfizer, Inc.
Puma Biotechnology, Inc.
Roche (F. Hoffman-La Roche, Ltd.)
Sanofi/Genzyme
Seagen Inc.
Takeda
Segment by Type
Monoclonal Antibodies
Kinase Inhibitors
Angiogenesis Inhibitors
Proteasome Inhibitors
CAR-T Therapies
Other Precision Therapies
Segment by Application
Breast Cancer
Lung Cancer
Prostate Cancer
Colon and Rectal Cancer
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Precision Cancer Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Precision Cancer Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Monoclonal Antibodies
1.2.3 Kinase Inhibitors
1.2.4 Angiogenesis Inhibitors
1.2.5 Proteasome Inhibitors
1.2.6 CAR-T Therapies
1.2.7 Other Precision Therapies
1.3 Market by Application
1.3.1 Global Precision Cancer Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Breast Cancer
1.3.3 Lung Cancer
1.3.4 Prostate Cancer
1.3.5 Colon and Rectal Cancer
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Precision Cancer Therapeutics Market Perspective (2020-2031)
2.2 Global Precision Cancer Therapeutics Growth Trends by Region
2.2.1 Global Precision Cancer Therapeutics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Precision Cancer Therapeutics Historic Market Size by Region (2020-2025)
2.2.3 Precision Cancer Therapeutics Forecasted Market Size by Region (2026-2031)
2.3 Precision Cancer Therapeutics Market Dynamics
2.3.1 Precision Cancer Therapeutics Industry Trends
2.3.2 Precision Cancer Therapeutics Market Drivers
2.3.3 Precision Cancer Therapeutics Market Challenges
2.3.4 Precision Cancer Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Precision Cancer Therapeutics Players by Revenue
3.1.1 Global Top Precision Cancer Therapeutics Players by Revenue (2020-2025)
3.1.2 Global Precision Cancer Therapeutics Revenue Market Share by Players (2020-2025)
3.2 Global Precision Cancer Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Precision Cancer Therapeutics Revenue
3.4 Global Precision Cancer Therapeutics Market Concentration Ratio
3.4.1 Global Precision Cancer Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Precision Cancer Therapeutics Revenue in 2024
3.5 Global Key Players of Precision Cancer Therapeutics Head office and Area Served
3.6 Global Key Players of Precision Cancer Therapeutics, Product and Application
3.7 Global Key Players of Precision Cancer Therapeutics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Precision Cancer Therapeutics Breakdown Data by Type
4.1 Global Precision Cancer Therapeutics Historic Market Size by Type (2020-2025)
4.2 Global Precision Cancer Therapeutics Forecasted Market Size by Type (2026-2031)
5 Precision Cancer Therapeutics Breakdown Data by Application
5.1 Global Precision Cancer Therapeutics Historic Market Size by Application (2020-2025)
5.2 Global Precision Cancer Therapeutics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Precision Cancer Therapeutics Market Size (2020-2031)
6.2 North America Precision Cancer Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Precision Cancer Therapeutics Market Size by Country (2020-2025)
6.4 North America Precision Cancer Therapeutics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Precision Cancer Therapeutics Market Size (2020-2031)
7.2 Europe Precision Cancer Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Precision Cancer Therapeutics Market Size by Country (2020-2025)
7.4 Europe Precision Cancer Therapeutics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Precision Cancer Therapeutics Market Size (2020-2031)
8.2 Asia-Pacific Precision Cancer Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Precision Cancer Therapeutics Market Size by Region (2020-2025)
8.4 Asia-Pacific Precision Cancer Therapeutics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Precision Cancer Therapeutics Market Size (2020-2031)
9.2 Latin America Precision Cancer Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Precision Cancer Therapeutics Market Size by Country (2020-2025)
9.4 Latin America Precision Cancer Therapeutics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Precision Cancer Therapeutics Market Size (2020-2031)
10.2 Middle East & Africa Precision Cancer Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Precision Cancer Therapeutics Market Size by Country (2020-2025)
10.4 Middle East & Africa Precision Cancer Therapeutics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Details
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Precision Cancer Therapeutics Introduction
11.1.4 AbbVie Revenue in Precision Cancer Therapeutics Business (2020-2025)
11.1.5 AbbVie Recent Development
11.2 Astellas Pharma U.S., Inc
11.2.1 Astellas Pharma U.S., Inc Company Details
11.2.2 Astellas Pharma U.S., Inc Business Overview
11.2.3 Astellas Pharma U.S., Inc Precision Cancer Therapeutics Introduction
11.2.4 Astellas Pharma U.S., Inc Revenue in Precision Cancer Therapeutics Business (2020-2025)
11.2.5 Astellas Pharma U.S., Inc Recent Development
11.3 AstraZeneca PLC
11.3.1 AstraZeneca PLC Company Details
11.3.2 AstraZeneca PLC Business Overview
11.3.3 AstraZeneca PLC Precision Cancer Therapeutics Introduction
11.3.4 AstraZeneca PLC Revenue in Precision Cancer Therapeutics Business (2020-2025)
11.3.5 AstraZeneca PLC Recent Development
11.4 Bayer AG
11.4.1 Bayer AG Company Details
11.4.2 Bayer AG Business Overview
11.4.3 Bayer AG Precision Cancer Therapeutics Introduction
11.4.4 Bayer AG Revenue in Precision Cancer Therapeutics Business (2020-2025)
11.4.5 Bayer AG Recent Development
11.5 Bristol-Myers Squibb Company
11.5.1 Bristol-Myers Squibb Company Company Details
11.5.2 Bristol-Myers Squibb Company Business Overview
11.5.3 Bristol-Myers Squibb Company Precision Cancer Therapeutics Introduction
11.5.4 Bristol-Myers Squibb Company Revenue in Precision Cancer Therapeutics Business (2020-2025)
11.5.5 Bristol-Myers Squibb Company Recent Development
11.6 Clovis Oncology, Inc.
11.6.1 Clovis Oncology, Inc. Company Details
11.6.2 Clovis Oncology, Inc. Business Overview
11.6.3 Clovis Oncology, Inc. Precision Cancer Therapeutics Introduction
11.6.4 Clovis Oncology, Inc. Revenue in Precision Cancer Therapeutics Business (2020-2025)
11.6.5 Clovis Oncology, Inc. Recent Development
11.7 Dendreon Pharmaceuticals LLC
11.7.1 Dendreon Pharmaceuticals LLC Company Details
11.7.2 Dendreon Pharmaceuticals LLC Business Overview
11.7.3 Dendreon Pharmaceuticals LLC Precision Cancer Therapeutics Introduction
11.7.4 Dendreon Pharmaceuticals LLC Revenue in Precision Cancer Therapeutics Business (2020-2025)
11.7.5 Dendreon Pharmaceuticals LLC Recent Development
11.8 Eli Lilly & Company
11.8.1 Eli Lilly & Company Company Details
11.8.2 Eli Lilly & Company Business Overview
11.8.3 Eli Lilly & Company Precision Cancer Therapeutics Introduction
11.8.4 Eli Lilly & Company Revenue in Precision Cancer Therapeutics Business (2020-2025)
11.8.5 Eli Lilly & Company Recent Development
11.9 EMD Serono, Inc. (Merck KgaA)
11.9.1 EMD Serono, Inc. (Merck KgaA) Company Details
11.9.2 EMD Serono, Inc. (Merck KgaA) Business Overview
11.9.3 EMD Serono, Inc. (Merck KgaA) Precision Cancer Therapeutics Introduction
11.9.4 EMD Serono, Inc. (Merck KgaA) Revenue in Precision Cancer Therapeutics Business (2020-2025)
11.9.5 EMD Serono, Inc. (Merck KgaA) Recent Development
11.10 Eisai Co., Ltd.
11.10.1 Eisai Co., Ltd. Company Details
11.10.2 Eisai Co., Ltd. Business Overview
11.10.3 Eisai Co., Ltd. Precision Cancer Therapeutics Introduction
11.10.4 Eisai Co., Ltd. Revenue in Precision Cancer Therapeutics Business (2020-2025)
11.10.5 Eisai Co., Ltd. Recent Development
11.11 Exelixis, Inc.
11.11.1 Exelixis, Inc. Company Details
11.11.2 Exelixis, Inc. Business Overview
11.11.3 Exelixis, Inc. Precision Cancer Therapeutics Introduction
11.11.4 Exelixis, Inc. Revenue in Precision Cancer Therapeutics Business (2020-2025)
11.11.5 Exelixis, Inc. Recent Development
11.12 Gilead Sciences, Inc.
11.12.1 Gilead Sciences, Inc. Company Details
11.12.2 Gilead Sciences, Inc. Business Overview
11.12.3 Gilead Sciences, Inc. Precision Cancer Therapeutics Introduction
11.12.4 Gilead Sciences, Inc. Revenue in Precision Cancer Therapeutics Business (2020-2025)
11.12.5 Gilead Sciences, Inc. Recent Development
11.13 GlaxoSmithKline
11.13.1 GlaxoSmithKline Company Details
11.13.2 GlaxoSmithKline Business Overview
11.13.3 GlaxoSmithKline Precision Cancer Therapeutics Introduction
11.13.4 GlaxoSmithKline Revenue in Precision Cancer Therapeutics Business (2020-2025)
11.13.5 GlaxoSmithKline Recent Development
11.14 Johnson & Johnson
11.14.1 Johnson & Johnson Company Details
11.14.2 Johnson & Johnson Business Overview
11.14.3 Johnson & Johnson Precision Cancer Therapeutics Introduction
11.14.4 Johnson & Johnson Revenue in Precision Cancer Therapeutics Business (2020-2025)
11.14.5 Johnson & Johnson Recent Development
11.15 Merck & Co., Inc.
11.15.1 Merck & Co., Inc. Company Details
11.15.2 Merck & Co., Inc. Business Overview
11.15.3 Merck & Co., Inc. Precision Cancer Therapeutics Introduction
11.15.4 Merck & Co., Inc. Revenue in Precision Cancer Therapeutics Business (2020-2025)
11.15.5 Merck & Co., Inc. Recent Development
11.16 Novartis AG
11.16.1 Novartis AG Company Details
11.16.2 Novartis AG Business Overview
11.16.3 Novartis AG Precision Cancer Therapeutics Introduction
11.16.4 Novartis AG Revenue in Precision Cancer Therapeutics Business (2020-2025)
11.16.5 Novartis AG Recent Development
11.17 Otsuka Holdings Co., Ltd.
11.17.1 Otsuka Holdings Co., Ltd. Company Details
11.17.2 Otsuka Holdings Co., Ltd. Business Overview
11.17.3 Otsuka Holdings Co., Ltd. Precision Cancer Therapeutics Introduction
11.17.4 Otsuka Holdings Co., Ltd. Revenue in Precision Cancer Therapeutics Business (2020-2025)
11.17.5 Otsuka Holdings Co., Ltd. Recent Development
11.18 Pfizer, Inc.
11.18.1 Pfizer, Inc. Company Details
11.18.2 Pfizer, Inc. Business Overview
11.18.3 Pfizer, Inc. Precision Cancer Therapeutics Introduction
11.18.4 Pfizer, Inc. Revenue in Precision Cancer Therapeutics Business (2020-2025)
11.18.5 Pfizer, Inc. Recent Development
11.19 Puma Biotechnology, Inc.
11.19.1 Puma Biotechnology, Inc. Company Details
11.19.2 Puma Biotechnology, Inc. Business Overview
11.19.3 Puma Biotechnology, Inc. Precision Cancer Therapeutics Introduction
11.19.4 Puma Biotechnology, Inc. Revenue in Precision Cancer Therapeutics Business (2020-2025)
11.19.5 Puma Biotechnology, Inc. Recent Development
11.20 Roche (F. Hoffman-La Roche, Ltd.)
11.20.1 Roche (F. Hoffman-La Roche, Ltd.) Company Details
11.20.2 Roche (F. Hoffman-La Roche, Ltd.) Business Overview
11.20.3 Roche (F. Hoffman-La Roche, Ltd.) Precision Cancer Therapeutics Introduction
11.20.4 Roche (F. Hoffman-La Roche, Ltd.) Revenue in Precision Cancer Therapeutics Business (2020-2025)
11.20.5 Roche (F. Hoffman-La Roche, Ltd.) Recent Development
11.21 Sanofi/Genzyme
11.21.1 Sanofi/Genzyme Company Details
11.21.2 Sanofi/Genzyme Business Overview
11.21.3 Sanofi/Genzyme Precision Cancer Therapeutics Introduction
11.21.4 Sanofi/Genzyme Revenue in Precision Cancer Therapeutics Business (2020-2025)
11.21.5 Sanofi/Genzyme Recent Development
11.22 Seagen Inc.
11.22.1 Seagen Inc. Company Details
11.22.2 Seagen Inc. Business Overview
11.22.3 Seagen Inc. Precision Cancer Therapeutics Introduction
11.22.4 Seagen Inc. Revenue in Precision Cancer Therapeutics Business (2020-2025)
11.22.5 Seagen Inc. Recent Development
11.23 Takeda
11.23.1 Takeda Company Details
11.23.2 Takeda Business Overview
11.23.3 Takeda Precision Cancer Therapeutics Introduction
11.23.4 Takeda Revenue in Precision Cancer Therapeutics Business (2020-2025)
11.23.5 Takeda Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Precision Cancer Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Monoclonal Antibodies
1.2.3 Kinase Inhibitors
1.2.4 Angiogenesis Inhibitors
1.2.5 Proteasome Inhibitors
1.2.6 CAR-T Therapies
1.2.7 Other Precision Therapies
1.3 Market by Application
1.3.1 Global Precision Cancer Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Breast Cancer
1.3.3 Lung Cancer
1.3.4 Prostate Cancer
1.3.5 Colon and Rectal Cancer
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Precision Cancer Therapeutics Market Perspective (2020-2031)
2.2 Global Precision Cancer Therapeutics Growth Trends by Region
2.2.1 Global Precision Cancer Therapeutics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Precision Cancer Therapeutics Historic Market Size by Region (2020-2025)
2.2.3 Precision Cancer Therapeutics Forecasted Market Size by Region (2026-2031)
2.3 Precision Cancer Therapeutics Market Dynamics
2.3.1 Precision Cancer Therapeutics Industry Trends
2.3.2 Precision Cancer Therapeutics Market Drivers
2.3.3 Precision Cancer Therapeutics Market Challenges
2.3.4 Precision Cancer Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Precision Cancer Therapeutics Players by Revenue
3.1.1 Global Top Precision Cancer Therapeutics Players by Revenue (2020-2025)
3.1.2 Global Precision Cancer Therapeutics Revenue Market Share by Players (2020-2025)
3.2 Global Precision Cancer Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Precision Cancer Therapeutics Revenue
3.4 Global Precision Cancer Therapeutics Market Concentration Ratio
3.4.1 Global Precision Cancer Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Precision Cancer Therapeutics Revenue in 2024
3.5 Global Key Players of Precision Cancer Therapeutics Head office and Area Served
3.6 Global Key Players of Precision Cancer Therapeutics, Product and Application
3.7 Global Key Players of Precision Cancer Therapeutics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Precision Cancer Therapeutics Breakdown Data by Type
4.1 Global Precision Cancer Therapeutics Historic Market Size by Type (2020-2025)
4.2 Global Precision Cancer Therapeutics Forecasted Market Size by Type (2026-2031)
5 Precision Cancer Therapeutics Breakdown Data by Application
5.1 Global Precision Cancer Therapeutics Historic Market Size by Application (2020-2025)
5.2 Global Precision Cancer Therapeutics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Precision Cancer Therapeutics Market Size (2020-2031)
6.2 North America Precision Cancer Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Precision Cancer Therapeutics Market Size by Country (2020-2025)
6.4 North America Precision Cancer Therapeutics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Precision Cancer Therapeutics Market Size (2020-2031)
7.2 Europe Precision Cancer Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Precision Cancer Therapeutics Market Size by Country (2020-2025)
7.4 Europe Precision Cancer Therapeutics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Precision Cancer Therapeutics Market Size (2020-2031)
8.2 Asia-Pacific Precision Cancer Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Precision Cancer Therapeutics Market Size by Region (2020-2025)
8.4 Asia-Pacific Precision Cancer Therapeutics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Precision Cancer Therapeutics Market Size (2020-2031)
9.2 Latin America Precision Cancer Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Precision Cancer Therapeutics Market Size by Country (2020-2025)
9.4 Latin America Precision Cancer Therapeutics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Precision Cancer Therapeutics Market Size (2020-2031)
10.2 Middle East & Africa Precision Cancer Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Precision Cancer Therapeutics Market Size by Country (2020-2025)
10.4 Middle East & Africa Precision Cancer Therapeutics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Details
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Precision Cancer Therapeutics Introduction
11.1.4 AbbVie Revenue in Precision Cancer Therapeutics Business (2020-2025)
11.1.5 AbbVie Recent Development
11.2 Astellas Pharma U.S., Inc
11.2.1 Astellas Pharma U.S., Inc Company Details
11.2.2 Astellas Pharma U.S., Inc Business Overview
11.2.3 Astellas Pharma U.S., Inc Precision Cancer Therapeutics Introduction
11.2.4 Astellas Pharma U.S., Inc Revenue in Precision Cancer Therapeutics Business (2020-2025)
11.2.5 Astellas Pharma U.S., Inc Recent Development
11.3 AstraZeneca PLC
11.3.1 AstraZeneca PLC Company Details
11.3.2 AstraZeneca PLC Business Overview
11.3.3 AstraZeneca PLC Precision Cancer Therapeutics Introduction
11.3.4 AstraZeneca PLC Revenue in Precision Cancer Therapeutics Business (2020-2025)
11.3.5 AstraZeneca PLC Recent Development
11.4 Bayer AG
11.4.1 Bayer AG Company Details
11.4.2 Bayer AG Business Overview
11.4.3 Bayer AG Precision Cancer Therapeutics Introduction
11.4.4 Bayer AG Revenue in Precision Cancer Therapeutics Business (2020-2025)
11.4.5 Bayer AG Recent Development
11.5 Bristol-Myers Squibb Company
11.5.1 Bristol-Myers Squibb Company Company Details
11.5.2 Bristol-Myers Squibb Company Business Overview
11.5.3 Bristol-Myers Squibb Company Precision Cancer Therapeutics Introduction
11.5.4 Bristol-Myers Squibb Company Revenue in Precision Cancer Therapeutics Business (2020-2025)
11.5.5 Bristol-Myers Squibb Company Recent Development
11.6 Clovis Oncology, Inc.
11.6.1 Clovis Oncology, Inc. Company Details
11.6.2 Clovis Oncology, Inc. Business Overview
11.6.3 Clovis Oncology, Inc. Precision Cancer Therapeutics Introduction
11.6.4 Clovis Oncology, Inc. Revenue in Precision Cancer Therapeutics Business (2020-2025)
11.6.5 Clovis Oncology, Inc. Recent Development
11.7 Dendreon Pharmaceuticals LLC
11.7.1 Dendreon Pharmaceuticals LLC Company Details
11.7.2 Dendreon Pharmaceuticals LLC Business Overview
11.7.3 Dendreon Pharmaceuticals LLC Precision Cancer Therapeutics Introduction
11.7.4 Dendreon Pharmaceuticals LLC Revenue in Precision Cancer Therapeutics Business (2020-2025)
11.7.5 Dendreon Pharmaceuticals LLC Recent Development
11.8 Eli Lilly & Company
11.8.1 Eli Lilly & Company Company Details
11.8.2 Eli Lilly & Company Business Overview
11.8.3 Eli Lilly & Company Precision Cancer Therapeutics Introduction
11.8.4 Eli Lilly & Company Revenue in Precision Cancer Therapeutics Business (2020-2025)
11.8.5 Eli Lilly & Company Recent Development
11.9 EMD Serono, Inc. (Merck KgaA)
11.9.1 EMD Serono, Inc. (Merck KgaA) Company Details
11.9.2 EMD Serono, Inc. (Merck KgaA) Business Overview
11.9.3 EMD Serono, Inc. (Merck KgaA) Precision Cancer Therapeutics Introduction
11.9.4 EMD Serono, Inc. (Merck KgaA) Revenue in Precision Cancer Therapeutics Business (2020-2025)
11.9.5 EMD Serono, Inc. (Merck KgaA) Recent Development
11.10 Eisai Co., Ltd.
11.10.1 Eisai Co., Ltd. Company Details
11.10.2 Eisai Co., Ltd. Business Overview
11.10.3 Eisai Co., Ltd. Precision Cancer Therapeutics Introduction
11.10.4 Eisai Co., Ltd. Revenue in Precision Cancer Therapeutics Business (2020-2025)
11.10.5 Eisai Co., Ltd. Recent Development
11.11 Exelixis, Inc.
11.11.1 Exelixis, Inc. Company Details
11.11.2 Exelixis, Inc. Business Overview
11.11.3 Exelixis, Inc. Precision Cancer Therapeutics Introduction
11.11.4 Exelixis, Inc. Revenue in Precision Cancer Therapeutics Business (2020-2025)
11.11.5 Exelixis, Inc. Recent Development
11.12 Gilead Sciences, Inc.
11.12.1 Gilead Sciences, Inc. Company Details
11.12.2 Gilead Sciences, Inc. Business Overview
11.12.3 Gilead Sciences, Inc. Precision Cancer Therapeutics Introduction
11.12.4 Gilead Sciences, Inc. Revenue in Precision Cancer Therapeutics Business (2020-2025)
11.12.5 Gilead Sciences, Inc. Recent Development
11.13 GlaxoSmithKline
11.13.1 GlaxoSmithKline Company Details
11.13.2 GlaxoSmithKline Business Overview
11.13.3 GlaxoSmithKline Precision Cancer Therapeutics Introduction
11.13.4 GlaxoSmithKline Revenue in Precision Cancer Therapeutics Business (2020-2025)
11.13.5 GlaxoSmithKline Recent Development
11.14 Johnson & Johnson
11.14.1 Johnson & Johnson Company Details
11.14.2 Johnson & Johnson Business Overview
11.14.3 Johnson & Johnson Precision Cancer Therapeutics Introduction
11.14.4 Johnson & Johnson Revenue in Precision Cancer Therapeutics Business (2020-2025)
11.14.5 Johnson & Johnson Recent Development
11.15 Merck & Co., Inc.
11.15.1 Merck & Co., Inc. Company Details
11.15.2 Merck & Co., Inc. Business Overview
11.15.3 Merck & Co., Inc. Precision Cancer Therapeutics Introduction
11.15.4 Merck & Co., Inc. Revenue in Precision Cancer Therapeutics Business (2020-2025)
11.15.5 Merck & Co., Inc. Recent Development
11.16 Novartis AG
11.16.1 Novartis AG Company Details
11.16.2 Novartis AG Business Overview
11.16.3 Novartis AG Precision Cancer Therapeutics Introduction
11.16.4 Novartis AG Revenue in Precision Cancer Therapeutics Business (2020-2025)
11.16.5 Novartis AG Recent Development
11.17 Otsuka Holdings Co., Ltd.
11.17.1 Otsuka Holdings Co., Ltd. Company Details
11.17.2 Otsuka Holdings Co., Ltd. Business Overview
11.17.3 Otsuka Holdings Co., Ltd. Precision Cancer Therapeutics Introduction
11.17.4 Otsuka Holdings Co., Ltd. Revenue in Precision Cancer Therapeutics Business (2020-2025)
11.17.5 Otsuka Holdings Co., Ltd. Recent Development
11.18 Pfizer, Inc.
11.18.1 Pfizer, Inc. Company Details
11.18.2 Pfizer, Inc. Business Overview
11.18.3 Pfizer, Inc. Precision Cancer Therapeutics Introduction
11.18.4 Pfizer, Inc. Revenue in Precision Cancer Therapeutics Business (2020-2025)
11.18.5 Pfizer, Inc. Recent Development
11.19 Puma Biotechnology, Inc.
11.19.1 Puma Biotechnology, Inc. Company Details
11.19.2 Puma Biotechnology, Inc. Business Overview
11.19.3 Puma Biotechnology, Inc. Precision Cancer Therapeutics Introduction
11.19.4 Puma Biotechnology, Inc. Revenue in Precision Cancer Therapeutics Business (2020-2025)
11.19.5 Puma Biotechnology, Inc. Recent Development
11.20 Roche (F. Hoffman-La Roche, Ltd.)
11.20.1 Roche (F. Hoffman-La Roche, Ltd.) Company Details
11.20.2 Roche (F. Hoffman-La Roche, Ltd.) Business Overview
11.20.3 Roche (F. Hoffman-La Roche, Ltd.) Precision Cancer Therapeutics Introduction
11.20.4 Roche (F. Hoffman-La Roche, Ltd.) Revenue in Precision Cancer Therapeutics Business (2020-2025)
11.20.5 Roche (F. Hoffman-La Roche, Ltd.) Recent Development
11.21 Sanofi/Genzyme
11.21.1 Sanofi/Genzyme Company Details
11.21.2 Sanofi/Genzyme Business Overview
11.21.3 Sanofi/Genzyme Precision Cancer Therapeutics Introduction
11.21.4 Sanofi/Genzyme Revenue in Precision Cancer Therapeutics Business (2020-2025)
11.21.5 Sanofi/Genzyme Recent Development
11.22 Seagen Inc.
11.22.1 Seagen Inc. Company Details
11.22.2 Seagen Inc. Business Overview
11.22.3 Seagen Inc. Precision Cancer Therapeutics Introduction
11.22.4 Seagen Inc. Revenue in Precision Cancer Therapeutics Business (2020-2025)
11.22.5 Seagen Inc. Recent Development
11.23 Takeda
11.23.1 Takeda Company Details
11.23.2 Takeda Business Overview
11.23.3 Takeda Precision Cancer Therapeutics Introduction
11.23.4 Takeda Revenue in Precision Cancer Therapeutics Business (2020-2025)
11.23.5 Takeda Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Precision Cancer Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Monoclonal Antibodies
Table 3. Key Players of Kinase Inhibitors
Table 4. Key Players of Angiogenesis Inhibitors
Table 5. Key Players of Proteasome Inhibitors
Table 6. Key Players of CAR-T Therapies
Table 7. Key Players of Other Precision Therapies
Table 8. Global Precision Cancer Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Precision Cancer Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 10. Global Precision Cancer Therapeutics Market Size by Region (2020-2025) & (US$ Million)
Table 11. Global Precision Cancer Therapeutics Market Share by Region (2020-2025)
Table 12. Global Precision Cancer Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 13. Global Precision Cancer Therapeutics Market Share by Region (2026-2031)
Table 14. Precision Cancer Therapeutics Market Trends
Table 15. Precision Cancer Therapeutics Market Drivers
Table 16. Precision Cancer Therapeutics Market Challenges
Table 17. Precision Cancer Therapeutics Market Restraints
Table 18. Global Precision Cancer Therapeutics Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Precision Cancer Therapeutics Market Share by Players (2020-2025)
Table 20. Global Top Precision Cancer Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Precision Cancer Therapeutics as of 2024)
Table 21. Ranking of Global Top Precision Cancer Therapeutics Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Precision Cancer Therapeutics Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Precision Cancer Therapeutics, Headquarters and Area Served
Table 24. Global Key Players of Precision Cancer Therapeutics, Product and Application
Table 25. Global Key Players of Precision Cancer Therapeutics, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Precision Cancer Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 28. Global Precision Cancer Therapeutics Revenue Market Share by Type (2020-2025)
Table 29. Global Precision Cancer Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 30. Global Precision Cancer Therapeutics Revenue Market Share by Type (2026-2031)
Table 31. Global Precision Cancer Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 32. Global Precision Cancer Therapeutics Revenue Market Share by Application (2020-2025)
Table 33. Global Precision Cancer Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 34. Global Precision Cancer Therapeutics Revenue Market Share by Application (2026-2031)
Table 35. North America Precision Cancer Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. North America Precision Cancer Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 37. North America Precision Cancer Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 38. Europe Precision Cancer Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 39. Europe Precision Cancer Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 40. Europe Precision Cancer Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 41. Asia-Pacific Precision Cancer Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 42. Asia-Pacific Precision Cancer Therapeutics Market Size by Region (2020-2025) & (US$ Million)
Table 43. Asia-Pacific Precision Cancer Therapeutics Market Size by Region (2026-2031) & (US$ Million)
Table 44. Latin America Precision Cancer Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Latin America Precision Cancer Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 46. Latin America Precision Cancer Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 47. Middle East & Africa Precision Cancer Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 48. Middle East & Africa Precision Cancer Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 49. Middle East & Africa Precision Cancer Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 50. AbbVie Company Details
Table 51. AbbVie Business Overview
Table 52. AbbVie Precision Cancer Therapeutics Product
Table 53. AbbVie Revenue in Precision Cancer Therapeutics Business (2020-2025) & (US$ Million)
Table 54. AbbVie Recent Development
Table 55. Astellas Pharma U.S., Inc Company Details
Table 56. Astellas Pharma U.S., Inc Business Overview
Table 57. Astellas Pharma U.S., Inc Precision Cancer Therapeutics Product
Table 58. Astellas Pharma U.S., Inc Revenue in Precision Cancer Therapeutics Business (2020-2025) & (US$ Million)
Table 59. Astellas Pharma U.S., Inc Recent Development
Table 60. AstraZeneca PLC Company Details
Table 61. AstraZeneca PLC Business Overview
Table 62. AstraZeneca PLC Precision Cancer Therapeutics Product
Table 63. AstraZeneca PLC Revenue in Precision Cancer Therapeutics Business (2020-2025) & (US$ Million)
Table 64. AstraZeneca PLC Recent Development
Table 65. Bayer AG Company Details
Table 66. Bayer AG Business Overview
Table 67. Bayer AG Precision Cancer Therapeutics Product
Table 68. Bayer AG Revenue in Precision Cancer Therapeutics Business (2020-2025) & (US$ Million)
Table 69. Bayer AG Recent Development
Table 70. Bristol-Myers Squibb Company Company Details
Table 71. Bristol-Myers Squibb Company Business Overview
Table 72. Bristol-Myers Squibb Company Precision Cancer Therapeutics Product
Table 73. Bristol-Myers Squibb Company Revenue in Precision Cancer Therapeutics Business (2020-2025) & (US$ Million)
Table 74. Bristol-Myers Squibb Company Recent Development
Table 75. Clovis Oncology, Inc. Company Details
Table 76. Clovis Oncology, Inc. Business Overview
Table 77. Clovis Oncology, Inc. Precision Cancer Therapeutics Product
Table 78. Clovis Oncology, Inc. Revenue in Precision Cancer Therapeutics Business (2020-2025) & (US$ Million)
Table 79. Clovis Oncology, Inc. Recent Development
Table 80. Dendreon Pharmaceuticals LLC Company Details
Table 81. Dendreon Pharmaceuticals LLC Business Overview
Table 82. Dendreon Pharmaceuticals LLC Precision Cancer Therapeutics Product
Table 83. Dendreon Pharmaceuticals LLC Revenue in Precision Cancer Therapeutics Business (2020-2025) & (US$ Million)
Table 84. Dendreon Pharmaceuticals LLC Recent Development
Table 85. Eli Lilly & Company Company Details
Table 86. Eli Lilly & Company Business Overview
Table 87. Eli Lilly & Company Precision Cancer Therapeutics Product
Table 88. Eli Lilly & Company Revenue in Precision Cancer Therapeutics Business (2020-2025) & (US$ Million)
Table 89. Eli Lilly & Company Recent Development
Table 90. EMD Serono, Inc. (Merck KgaA) Company Details
Table 91. EMD Serono, Inc. (Merck KgaA) Business Overview
Table 92. EMD Serono, Inc. (Merck KgaA) Precision Cancer Therapeutics Product
Table 93. EMD Serono, Inc. (Merck KgaA) Revenue in Precision Cancer Therapeutics Business (2020-2025) & (US$ Million)
Table 94. EMD Serono, Inc. (Merck KgaA) Recent Development
Table 95. Eisai Co., Ltd. Company Details
Table 96. Eisai Co., Ltd. Business Overview
Table 97. Eisai Co., Ltd. Precision Cancer Therapeutics Product
Table 98. Eisai Co., Ltd. Revenue in Precision Cancer Therapeutics Business (2020-2025) & (US$ Million)
Table 99. Eisai Co., Ltd. Recent Development
Table 100. Exelixis, Inc. Company Details
Table 101. Exelixis, Inc. Business Overview
Table 102. Exelixis, Inc. Precision Cancer Therapeutics Product
Table 103. Exelixis, Inc. Revenue in Precision Cancer Therapeutics Business (2020-2025) & (US$ Million)
Table 104. Exelixis, Inc. Recent Development
Table 105. Gilead Sciences, Inc. Company Details
Table 106. Gilead Sciences, Inc. Business Overview
Table 107. Gilead Sciences, Inc. Precision Cancer Therapeutics Product
Table 108. Gilead Sciences, Inc. Revenue in Precision Cancer Therapeutics Business (2020-2025) & (US$ Million)
Table 109. Gilead Sciences, Inc. Recent Development
Table 110. GlaxoSmithKline Company Details
Table 111. GlaxoSmithKline Business Overview
Table 112. GlaxoSmithKline Precision Cancer Therapeutics Product
Table 113. GlaxoSmithKline Revenue in Precision Cancer Therapeutics Business (2020-2025) & (US$ Million)
Table 114. GlaxoSmithKline Recent Development
Table 115. Johnson & Johnson Company Details
Table 116. Johnson & Johnson Business Overview
Table 117. Johnson & Johnson Precision Cancer Therapeutics Product
Table 118. Johnson & Johnson Revenue in Precision Cancer Therapeutics Business (2020-2025) & (US$ Million)
Table 119. Johnson & Johnson Recent Development
Table 120. Merck & Co., Inc. Company Details
Table 121. Merck & Co., Inc. Business Overview
Table 122. Merck & Co., Inc. Precision Cancer Therapeutics Product
Table 123. Merck & Co., Inc. Revenue in Precision Cancer Therapeutics Business (2020-2025) & (US$ Million)
Table 124. Merck & Co., Inc. Recent Development
Table 125. Novartis AG Company Details
Table 126. Novartis AG Business Overview
Table 127. Novartis AG Precision Cancer Therapeutics Product
Table 128. Novartis AG Revenue in Precision Cancer Therapeutics Business (2020-2025) & (US$ Million)
Table 129. Novartis AG Recent Development
Table 130. Otsuka Holdings Co., Ltd. Company Details
Table 131. Otsuka Holdings Co., Ltd. Business Overview
Table 132. Otsuka Holdings Co., Ltd. Precision Cancer Therapeutics Product
Table 133. Otsuka Holdings Co., Ltd. Revenue in Precision Cancer Therapeutics Business (2020-2025) & (US$ Million)
Table 134. Otsuka Holdings Co., Ltd. Recent Development
Table 135. Pfizer, Inc. Company Details
Table 136. Pfizer, Inc. Business Overview
Table 137. Pfizer, Inc. Precision Cancer Therapeutics Product
Table 138. Pfizer, Inc. Revenue in Precision Cancer Therapeutics Business (2020-2025) & (US$ Million)
Table 139. Pfizer, Inc. Recent Development
Table 140. Puma Biotechnology, Inc. Company Details
Table 141. Puma Biotechnology, Inc. Business Overview
Table 142. Puma Biotechnology, Inc. Precision Cancer Therapeutics Product
Table 143. Puma Biotechnology, Inc. Revenue in Precision Cancer Therapeutics Business (2020-2025) & (US$ Million)
Table 144. Puma Biotechnology, Inc. Recent Development
Table 145. Roche (F. Hoffman-La Roche, Ltd.) Company Details
Table 146. Roche (F. Hoffman-La Roche, Ltd.) Business Overview
Table 147. Roche (F. Hoffman-La Roche, Ltd.) Precision Cancer Therapeutics Product
Table 148. Roche (F. Hoffman-La Roche, Ltd.) Revenue in Precision Cancer Therapeutics Business (2020-2025) & (US$ Million)
Table 149. Roche (F. Hoffman-La Roche, Ltd.) Recent Development
Table 150. Sanofi/Genzyme Company Details
Table 151. Sanofi/Genzyme Business Overview
Table 152. Sanofi/Genzyme Precision Cancer Therapeutics Product
Table 153. Sanofi/Genzyme Revenue in Precision Cancer Therapeutics Business (2020-2025) & (US$ Million)
Table 154. Sanofi/Genzyme Recent Development
Table 155. Seagen Inc. Company Details
Table 156. Seagen Inc. Business Overview
Table 157. Seagen Inc. Precision Cancer Therapeutics Product
Table 158. Seagen Inc. Revenue in Precision Cancer Therapeutics Business (2020-2025) & (US$ Million)
Table 159. Seagen Inc. Recent Development
Table 160. Takeda Company Details
Table 161. Takeda Business Overview
Table 162. Takeda Precision Cancer Therapeutics Product
Table 163. Takeda Revenue in Precision Cancer Therapeutics Business (2020-2025) & (US$ Million)
Table 164. Takeda Recent Development
Table 165. Research Programs/Design for This Report
Table 166. Key Data Information from Secondary Sources
Table 167. Key Data Information from Primary Sources
Table 168. Authors List of This Report
List of Figures
Figure 1. Precision Cancer Therapeutics Picture
Figure 2. Global Precision Cancer Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Precision Cancer Therapeutics Market Share by Type: 2024 VS 2031
Figure 4. Monoclonal Antibodies Features
Figure 5. Kinase Inhibitors Features
Figure 6. Angiogenesis Inhibitors Features
Figure 7. Proteasome Inhibitors Features
Figure 8. CAR-T Therapies Features
Figure 9. Other Precision Therapies Features
Figure 10. Global Precision Cancer Therapeutics Market Size by Application (2020-2031) & (US$ Million)
Figure 11. Global Precision Cancer Therapeutics Market Share by Application: 2024 VS 2031
Figure 12. Breast Cancer Case Studies
Figure 13. Lung Cancer Case Studies
Figure 14. Prostate Cancer Case Studies
Figure 15. Colon and Rectal Cancer Case Studies
Figure 16. Others Case Studies
Figure 17. Precision Cancer Therapeutics Report Years Considered
Figure 18. Global Precision Cancer Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 19. Global Precision Cancer Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 20. Global Precision Cancer Therapeutics Market Share by Region: 2024 VS 2031
Figure 21. Global Precision Cancer Therapeutics Market Share by Players in 2024
Figure 22. Global Top Precision Cancer Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Precision Cancer Therapeutics as of 2024)
Figure 23. The Top 10 and 5 Players Market Share by Precision Cancer Therapeutics Revenue in 2024
Figure 24. North America Precision Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. North America Precision Cancer Therapeutics Market Share by Country (2020-2031)
Figure 26. United States Precision Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Canada Precision Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Europe Precision Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Europe Precision Cancer Therapeutics Market Share by Country (2020-2031)
Figure 30. Germany Precision Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. France Precision Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. U.K. Precision Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Italy Precision Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Russia Precision Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Nordic Countries Precision Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Asia-Pacific Precision Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Asia-Pacific Precision Cancer Therapeutics Market Share by Region (2020-2031)
Figure 38. China Precision Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Japan Precision Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. South Korea Precision Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Southeast Asia Precision Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. India Precision Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Australia Precision Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Latin America Precision Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Latin America Precision Cancer Therapeutics Market Share by Country (2020-2031)
Figure 46. Mexico Precision Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Brazil Precision Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Middle East & Africa Precision Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Middle East & Africa Precision Cancer Therapeutics Market Share by Country (2020-2031)
Figure 50. Turkey Precision Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Precision Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. UAE Precision Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 53. AbbVie Revenue Growth Rate in Precision Cancer Therapeutics Business (2020-2025)
Figure 54. Astellas Pharma U.S., Inc Revenue Growth Rate in Precision Cancer Therapeutics Business (2020-2025)
Figure 55. AstraZeneca PLC Revenue Growth Rate in Precision Cancer Therapeutics Business (2020-2025)
Figure 56. Bayer AG Revenue Growth Rate in Precision Cancer Therapeutics Business (2020-2025)
Figure 57. Bristol-Myers Squibb Company Revenue Growth Rate in Precision Cancer Therapeutics Business (2020-2025)
Figure 58. Clovis Oncology, Inc. Revenue Growth Rate in Precision Cancer Therapeutics Business (2020-2025)
Figure 59. Dendreon Pharmaceuticals LLC Revenue Growth Rate in Precision Cancer Therapeutics Business (2020-2025)
Figure 60. Eli Lilly & Company Revenue Growth Rate in Precision Cancer Therapeutics Business (2020-2025)
Figure 61. EMD Serono, Inc. (Merck KgaA) Revenue Growth Rate in Precision Cancer Therapeutics Business (2020-2025)
Figure 62. Eisai Co., Ltd. Revenue Growth Rate in Precision Cancer Therapeutics Business (2020-2025)
Figure 63. Exelixis, Inc. Revenue Growth Rate in Precision Cancer Therapeutics Business (2020-2025)
Figure 64. Gilead Sciences, Inc. Revenue Growth Rate in Precision Cancer Therapeutics Business (2020-2025)
Figure 65. GlaxoSmithKline Revenue Growth Rate in Precision Cancer Therapeutics Business (2020-2025)
Figure 66. Johnson & Johnson Revenue Growth Rate in Precision Cancer Therapeutics Business (2020-2025)
Figure 67. Merck & Co., Inc. Revenue Growth Rate in Precision Cancer Therapeutics Business (2020-2025)
Figure 68. Novartis AG Revenue Growth Rate in Precision Cancer Therapeutics Business (2020-2025)
Figure 69. Otsuka Holdings Co., Ltd. Revenue Growth Rate in Precision Cancer Therapeutics Business (2020-2025)
Figure 70. Pfizer, Inc. Revenue Growth Rate in Precision Cancer Therapeutics Business (2020-2025)
Figure 71. Puma Biotechnology, Inc. Revenue Growth Rate in Precision Cancer Therapeutics Business (2020-2025)
Figure 72. Roche (F. Hoffman-La Roche, Ltd.) Revenue Growth Rate in Precision Cancer Therapeutics Business (2020-2025)
Figure 73. Sanofi/Genzyme Revenue Growth Rate in Precision Cancer Therapeutics Business (2020-2025)
Figure 74. Seagen Inc. Revenue Growth Rate in Precision Cancer Therapeutics Business (2020-2025)
Figure 75. Takeda Revenue Growth Rate in Precision Cancer Therapeutics Business (2020-2025)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed
Table 1. Global Precision Cancer Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Monoclonal Antibodies
Table 3. Key Players of Kinase Inhibitors
Table 4. Key Players of Angiogenesis Inhibitors
Table 5. Key Players of Proteasome Inhibitors
Table 6. Key Players of CAR-T Therapies
Table 7. Key Players of Other Precision Therapies
Table 8. Global Precision Cancer Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Precision Cancer Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 10. Global Precision Cancer Therapeutics Market Size by Region (2020-2025) & (US$ Million)
Table 11. Global Precision Cancer Therapeutics Market Share by Region (2020-2025)
Table 12. Global Precision Cancer Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 13. Global Precision Cancer Therapeutics Market Share by Region (2026-2031)
Table 14. Precision Cancer Therapeutics Market Trends
Table 15. Precision Cancer Therapeutics Market Drivers
Table 16. Precision Cancer Therapeutics Market Challenges
Table 17. Precision Cancer Therapeutics Market Restraints
Table 18. Global Precision Cancer Therapeutics Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Precision Cancer Therapeutics Market Share by Players (2020-2025)
Table 20. Global Top Precision Cancer Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Precision Cancer Therapeutics as of 2024)
Table 21. Ranking of Global Top Precision Cancer Therapeutics Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Precision Cancer Therapeutics Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Precision Cancer Therapeutics, Headquarters and Area Served
Table 24. Global Key Players of Precision Cancer Therapeutics, Product and Application
Table 25. Global Key Players of Precision Cancer Therapeutics, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Precision Cancer Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 28. Global Precision Cancer Therapeutics Revenue Market Share by Type (2020-2025)
Table 29. Global Precision Cancer Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 30. Global Precision Cancer Therapeutics Revenue Market Share by Type (2026-2031)
Table 31. Global Precision Cancer Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 32. Global Precision Cancer Therapeutics Revenue Market Share by Application (2020-2025)
Table 33. Global Precision Cancer Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 34. Global Precision Cancer Therapeutics Revenue Market Share by Application (2026-2031)
Table 35. North America Precision Cancer Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. North America Precision Cancer Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 37. North America Precision Cancer Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 38. Europe Precision Cancer Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 39. Europe Precision Cancer Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 40. Europe Precision Cancer Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 41. Asia-Pacific Precision Cancer Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 42. Asia-Pacific Precision Cancer Therapeutics Market Size by Region (2020-2025) & (US$ Million)
Table 43. Asia-Pacific Precision Cancer Therapeutics Market Size by Region (2026-2031) & (US$ Million)
Table 44. Latin America Precision Cancer Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Latin America Precision Cancer Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 46. Latin America Precision Cancer Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 47. Middle East & Africa Precision Cancer Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 48. Middle East & Africa Precision Cancer Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 49. Middle East & Africa Precision Cancer Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 50. AbbVie Company Details
Table 51. AbbVie Business Overview
Table 52. AbbVie Precision Cancer Therapeutics Product
Table 53. AbbVie Revenue in Precision Cancer Therapeutics Business (2020-2025) & (US$ Million)
Table 54. AbbVie Recent Development
Table 55. Astellas Pharma U.S., Inc Company Details
Table 56. Astellas Pharma U.S., Inc Business Overview
Table 57. Astellas Pharma U.S., Inc Precision Cancer Therapeutics Product
Table 58. Astellas Pharma U.S., Inc Revenue in Precision Cancer Therapeutics Business (2020-2025) & (US$ Million)
Table 59. Astellas Pharma U.S., Inc Recent Development
Table 60. AstraZeneca PLC Company Details
Table 61. AstraZeneca PLC Business Overview
Table 62. AstraZeneca PLC Precision Cancer Therapeutics Product
Table 63. AstraZeneca PLC Revenue in Precision Cancer Therapeutics Business (2020-2025) & (US$ Million)
Table 64. AstraZeneca PLC Recent Development
Table 65. Bayer AG Company Details
Table 66. Bayer AG Business Overview
Table 67. Bayer AG Precision Cancer Therapeutics Product
Table 68. Bayer AG Revenue in Precision Cancer Therapeutics Business (2020-2025) & (US$ Million)
Table 69. Bayer AG Recent Development
Table 70. Bristol-Myers Squibb Company Company Details
Table 71. Bristol-Myers Squibb Company Business Overview
Table 72. Bristol-Myers Squibb Company Precision Cancer Therapeutics Product
Table 73. Bristol-Myers Squibb Company Revenue in Precision Cancer Therapeutics Business (2020-2025) & (US$ Million)
Table 74. Bristol-Myers Squibb Company Recent Development
Table 75. Clovis Oncology, Inc. Company Details
Table 76. Clovis Oncology, Inc. Business Overview
Table 77. Clovis Oncology, Inc. Precision Cancer Therapeutics Product
Table 78. Clovis Oncology, Inc. Revenue in Precision Cancer Therapeutics Business (2020-2025) & (US$ Million)
Table 79. Clovis Oncology, Inc. Recent Development
Table 80. Dendreon Pharmaceuticals LLC Company Details
Table 81. Dendreon Pharmaceuticals LLC Business Overview
Table 82. Dendreon Pharmaceuticals LLC Precision Cancer Therapeutics Product
Table 83. Dendreon Pharmaceuticals LLC Revenue in Precision Cancer Therapeutics Business (2020-2025) & (US$ Million)
Table 84. Dendreon Pharmaceuticals LLC Recent Development
Table 85. Eli Lilly & Company Company Details
Table 86. Eli Lilly & Company Business Overview
Table 87. Eli Lilly & Company Precision Cancer Therapeutics Product
Table 88. Eli Lilly & Company Revenue in Precision Cancer Therapeutics Business (2020-2025) & (US$ Million)
Table 89. Eli Lilly & Company Recent Development
Table 90. EMD Serono, Inc. (Merck KgaA) Company Details
Table 91. EMD Serono, Inc. (Merck KgaA) Business Overview
Table 92. EMD Serono, Inc. (Merck KgaA) Precision Cancer Therapeutics Product
Table 93. EMD Serono, Inc. (Merck KgaA) Revenue in Precision Cancer Therapeutics Business (2020-2025) & (US$ Million)
Table 94. EMD Serono, Inc. (Merck KgaA) Recent Development
Table 95. Eisai Co., Ltd. Company Details
Table 96. Eisai Co., Ltd. Business Overview
Table 97. Eisai Co., Ltd. Precision Cancer Therapeutics Product
Table 98. Eisai Co., Ltd. Revenue in Precision Cancer Therapeutics Business (2020-2025) & (US$ Million)
Table 99. Eisai Co., Ltd. Recent Development
Table 100. Exelixis, Inc. Company Details
Table 101. Exelixis, Inc. Business Overview
Table 102. Exelixis, Inc. Precision Cancer Therapeutics Product
Table 103. Exelixis, Inc. Revenue in Precision Cancer Therapeutics Business (2020-2025) & (US$ Million)
Table 104. Exelixis, Inc. Recent Development
Table 105. Gilead Sciences, Inc. Company Details
Table 106. Gilead Sciences, Inc. Business Overview
Table 107. Gilead Sciences, Inc. Precision Cancer Therapeutics Product
Table 108. Gilead Sciences, Inc. Revenue in Precision Cancer Therapeutics Business (2020-2025) & (US$ Million)
Table 109. Gilead Sciences, Inc. Recent Development
Table 110. GlaxoSmithKline Company Details
Table 111. GlaxoSmithKline Business Overview
Table 112. GlaxoSmithKline Precision Cancer Therapeutics Product
Table 113. GlaxoSmithKline Revenue in Precision Cancer Therapeutics Business (2020-2025) & (US$ Million)
Table 114. GlaxoSmithKline Recent Development
Table 115. Johnson & Johnson Company Details
Table 116. Johnson & Johnson Business Overview
Table 117. Johnson & Johnson Precision Cancer Therapeutics Product
Table 118. Johnson & Johnson Revenue in Precision Cancer Therapeutics Business (2020-2025) & (US$ Million)
Table 119. Johnson & Johnson Recent Development
Table 120. Merck & Co., Inc. Company Details
Table 121. Merck & Co., Inc. Business Overview
Table 122. Merck & Co., Inc. Precision Cancer Therapeutics Product
Table 123. Merck & Co., Inc. Revenue in Precision Cancer Therapeutics Business (2020-2025) & (US$ Million)
Table 124. Merck & Co., Inc. Recent Development
Table 125. Novartis AG Company Details
Table 126. Novartis AG Business Overview
Table 127. Novartis AG Precision Cancer Therapeutics Product
Table 128. Novartis AG Revenue in Precision Cancer Therapeutics Business (2020-2025) & (US$ Million)
Table 129. Novartis AG Recent Development
Table 130. Otsuka Holdings Co., Ltd. Company Details
Table 131. Otsuka Holdings Co., Ltd. Business Overview
Table 132. Otsuka Holdings Co., Ltd. Precision Cancer Therapeutics Product
Table 133. Otsuka Holdings Co., Ltd. Revenue in Precision Cancer Therapeutics Business (2020-2025) & (US$ Million)
Table 134. Otsuka Holdings Co., Ltd. Recent Development
Table 135. Pfizer, Inc. Company Details
Table 136. Pfizer, Inc. Business Overview
Table 137. Pfizer, Inc. Precision Cancer Therapeutics Product
Table 138. Pfizer, Inc. Revenue in Precision Cancer Therapeutics Business (2020-2025) & (US$ Million)
Table 139. Pfizer, Inc. Recent Development
Table 140. Puma Biotechnology, Inc. Company Details
Table 141. Puma Biotechnology, Inc. Business Overview
Table 142. Puma Biotechnology, Inc. Precision Cancer Therapeutics Product
Table 143. Puma Biotechnology, Inc. Revenue in Precision Cancer Therapeutics Business (2020-2025) & (US$ Million)
Table 144. Puma Biotechnology, Inc. Recent Development
Table 145. Roche (F. Hoffman-La Roche, Ltd.) Company Details
Table 146. Roche (F. Hoffman-La Roche, Ltd.) Business Overview
Table 147. Roche (F. Hoffman-La Roche, Ltd.) Precision Cancer Therapeutics Product
Table 148. Roche (F. Hoffman-La Roche, Ltd.) Revenue in Precision Cancer Therapeutics Business (2020-2025) & (US$ Million)
Table 149. Roche (F. Hoffman-La Roche, Ltd.) Recent Development
Table 150. Sanofi/Genzyme Company Details
Table 151. Sanofi/Genzyme Business Overview
Table 152. Sanofi/Genzyme Precision Cancer Therapeutics Product
Table 153. Sanofi/Genzyme Revenue in Precision Cancer Therapeutics Business (2020-2025) & (US$ Million)
Table 154. Sanofi/Genzyme Recent Development
Table 155. Seagen Inc. Company Details
Table 156. Seagen Inc. Business Overview
Table 157. Seagen Inc. Precision Cancer Therapeutics Product
Table 158. Seagen Inc. Revenue in Precision Cancer Therapeutics Business (2020-2025) & (US$ Million)
Table 159. Seagen Inc. Recent Development
Table 160. Takeda Company Details
Table 161. Takeda Business Overview
Table 162. Takeda Precision Cancer Therapeutics Product
Table 163. Takeda Revenue in Precision Cancer Therapeutics Business (2020-2025) & (US$ Million)
Table 164. Takeda Recent Development
Table 165. Research Programs/Design for This Report
Table 166. Key Data Information from Secondary Sources
Table 167. Key Data Information from Primary Sources
Table 168. Authors List of This Report
List of Figures
Figure 1. Precision Cancer Therapeutics Picture
Figure 2. Global Precision Cancer Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Precision Cancer Therapeutics Market Share by Type: 2024 VS 2031
Figure 4. Monoclonal Antibodies Features
Figure 5. Kinase Inhibitors Features
Figure 6. Angiogenesis Inhibitors Features
Figure 7. Proteasome Inhibitors Features
Figure 8. CAR-T Therapies Features
Figure 9. Other Precision Therapies Features
Figure 10. Global Precision Cancer Therapeutics Market Size by Application (2020-2031) & (US$ Million)
Figure 11. Global Precision Cancer Therapeutics Market Share by Application: 2024 VS 2031
Figure 12. Breast Cancer Case Studies
Figure 13. Lung Cancer Case Studies
Figure 14. Prostate Cancer Case Studies
Figure 15. Colon and Rectal Cancer Case Studies
Figure 16. Others Case Studies
Figure 17. Precision Cancer Therapeutics Report Years Considered
Figure 18. Global Precision Cancer Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 19. Global Precision Cancer Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 20. Global Precision Cancer Therapeutics Market Share by Region: 2024 VS 2031
Figure 21. Global Precision Cancer Therapeutics Market Share by Players in 2024
Figure 22. Global Top Precision Cancer Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Precision Cancer Therapeutics as of 2024)
Figure 23. The Top 10 and 5 Players Market Share by Precision Cancer Therapeutics Revenue in 2024
Figure 24. North America Precision Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. North America Precision Cancer Therapeutics Market Share by Country (2020-2031)
Figure 26. United States Precision Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Canada Precision Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Europe Precision Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Europe Precision Cancer Therapeutics Market Share by Country (2020-2031)
Figure 30. Germany Precision Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. France Precision Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. U.K. Precision Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Italy Precision Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Russia Precision Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Nordic Countries Precision Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Asia-Pacific Precision Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Asia-Pacific Precision Cancer Therapeutics Market Share by Region (2020-2031)
Figure 38. China Precision Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Japan Precision Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. South Korea Precision Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Southeast Asia Precision Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. India Precision Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Australia Precision Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Latin America Precision Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Latin America Precision Cancer Therapeutics Market Share by Country (2020-2031)
Figure 46. Mexico Precision Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Brazil Precision Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Middle East & Africa Precision Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Middle East & Africa Precision Cancer Therapeutics Market Share by Country (2020-2031)
Figure 50. Turkey Precision Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Precision Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. UAE Precision Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 53. AbbVie Revenue Growth Rate in Precision Cancer Therapeutics Business (2020-2025)
Figure 54. Astellas Pharma U.S., Inc Revenue Growth Rate in Precision Cancer Therapeutics Business (2020-2025)
Figure 55. AstraZeneca PLC Revenue Growth Rate in Precision Cancer Therapeutics Business (2020-2025)
Figure 56. Bayer AG Revenue Growth Rate in Precision Cancer Therapeutics Business (2020-2025)
Figure 57. Bristol-Myers Squibb Company Revenue Growth Rate in Precision Cancer Therapeutics Business (2020-2025)
Figure 58. Clovis Oncology, Inc. Revenue Growth Rate in Precision Cancer Therapeutics Business (2020-2025)
Figure 59. Dendreon Pharmaceuticals LLC Revenue Growth Rate in Precision Cancer Therapeutics Business (2020-2025)
Figure 60. Eli Lilly & Company Revenue Growth Rate in Precision Cancer Therapeutics Business (2020-2025)
Figure 61. EMD Serono, Inc. (Merck KgaA) Revenue Growth Rate in Precision Cancer Therapeutics Business (2020-2025)
Figure 62. Eisai Co., Ltd. Revenue Growth Rate in Precision Cancer Therapeutics Business (2020-2025)
Figure 63. Exelixis, Inc. Revenue Growth Rate in Precision Cancer Therapeutics Business (2020-2025)
Figure 64. Gilead Sciences, Inc. Revenue Growth Rate in Precision Cancer Therapeutics Business (2020-2025)
Figure 65. GlaxoSmithKline Revenue Growth Rate in Precision Cancer Therapeutics Business (2020-2025)
Figure 66. Johnson & Johnson Revenue Growth Rate in Precision Cancer Therapeutics Business (2020-2025)
Figure 67. Merck & Co., Inc. Revenue Growth Rate in Precision Cancer Therapeutics Business (2020-2025)
Figure 68. Novartis AG Revenue Growth Rate in Precision Cancer Therapeutics Business (2020-2025)
Figure 69. Otsuka Holdings Co., Ltd. Revenue Growth Rate in Precision Cancer Therapeutics Business (2020-2025)
Figure 70. Pfizer, Inc. Revenue Growth Rate in Precision Cancer Therapeutics Business (2020-2025)
Figure 71. Puma Biotechnology, Inc. Revenue Growth Rate in Precision Cancer Therapeutics Business (2020-2025)
Figure 72. Roche (F. Hoffman-La Roche, Ltd.) Revenue Growth Rate in Precision Cancer Therapeutics Business (2020-2025)
Figure 73. Sanofi/Genzyme Revenue Growth Rate in Precision Cancer Therapeutics Business (2020-2025)
Figure 74. Seagen Inc. Revenue Growth Rate in Precision Cancer Therapeutics Business (2020-2025)
Figure 75. Takeda Revenue Growth Rate in Precision Cancer Therapeutics Business (2020-2025)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Potassium Bromide Windows Market Research Report 2025
Dec 14, 25
Global Bio-based 1,10-Decanediol Diacrylate Market Research Report 2025
Dec 14, 25
Global Bio-based 1,5-Pentanediol Diacrylate(PDDA) Market Research Report 2025
Dec 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232